NCT06363838

Brief Summary

In this prospective study, women aged between 40 and 75 years who had not undergone any vaginal surgery and had not undergone any abdominal prolapse surgery were included. Thirty-one women diagnosed with rectocele on examination were included in the study group. Thirty-one patients who underwent vaginal intervention and hysterectomy for reasons other than rectocele (colposcopy, conization, etc.) without anterior or posterior wall prolapse were included in the control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2020

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

April 9, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 12, 2024

Completed
Last Updated

April 12, 2024

Status Verified

March 1, 2024

Enrollment Period

7 months

First QC Date

April 9, 2024

Last Update Submit

April 9, 2024

Conditions

Keywords

posterior vaginal wallprolapsesmooth muscleactin

Outcome Measures

Primary Outcomes (2)

  • epithelial thickness

    Biopsy material was obtained from the epithelium of the posterior wall of the vagina, including the fascia that fits the Ap point. Immunohistochemical staining with Protein Gene Product 9.5 and smooth muscle α-actin was performed in the pathology laboratory

    one year

  • smooth muscle density

    Biopsy material was obtained from the epithelium of the posterior wall of the vagina, including the fascia that fits the Ap point. Immunohistochemical staining with Protein Gene Product 9.5 and smooth muscle α-actin was performed in the pathology laboratory

    one year

Study Arms (2)

study group

women aged between 40 and 75 years who had not undergone any vaginal surgery and had not undergone any abdominal prolapse surgery were included. Thirty-one women diagnosed with rectocele on examination were included in the study group.Biopsy material was obtained from the epithelium of the posterior wall of the vagina, including the fascia that fits the Ap point. Immunohistochemical staining with Protein Gene Product 9.5 and smooth muscle α-actin was performed in the pathology laboratory. The epithelial thickness measurement and smooth muscle density parameters obtained

control group

Thirty-one patients who underwent vaginal intervention and hysterectomy for reasons other than rectocele (colposcopy, conization, etc.) without anterior or posterior wall prolapse were included in the control group.Biopsy material was obtained from the epithelium of the posterior wall of the vagina, including the fascia that fits the Ap point. Immunohistochemical staining with Protein Gene Product 9.5 and smooth muscle α-actin was performed in the pathology laboratory. The epithelial thickness measurement and smooth muscle density parameters obtained

Eligibility Criteria

Age40 Years - 75 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAll participants were women because vaginal prolapse was evaluated.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The first group included women aged between 40-75 years, who had not undergone any vaginal surgery, had not undergone any abdominal uterine suspension surgery, had posterior wall prolapse, and for whom surgery was planned

You may qualify if:

  • Patients aged 40-75 years
  • Patients operated for prolapse
  • Patients who did not have prolapse and who would undergo vaginal intervention for other gynecologic reasons were designed to constitute the control group.
  • who had not undergone any vaginal surgery, had not undergone any abdominal uterine suspension surgery, had posterior wall prolapse, and for whom surgery was planned.

You may not qualify if:

  • Patients whose age was not suitable
  • who had previously undergone vaginal surgery, who had undergone abdominal surgery and a uterine suspension surgery, who were not suitable for the specified examination conditions
  • who had undergone rectocele surgery, urinary incontinence, or bladder surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hakan Timur

Ordu, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pelvic Organ ProlapseProlapse

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • HAKAN TİMUR

    ORDU UNIVERSTY

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2024

First Posted

April 12, 2024

Study Start

December 1, 2019

Primary Completion

June 25, 2020

Study Completion

June 30, 2020

Last Updated

April 12, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations